- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
- IMCD publishes convocation for its upcoming Annual General Meeting
- IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients
- IMCD further expands its food and nutrition footprint in Latin America with the acquisition of Bretano
- IMCD announces dividend proposal and Supervisory Board nominations for reappointment
- IMCD reports EBITA of EUR 515 million in 2023
- IMCD Australia and New Zealand strengthen its coatings and construction business with the acquisition of ResChem
- IMCD completes acquisition of remaining 30% of Signet Excipients Private Limited
- IMCD enhances its market presence in India with the acquisition of Valuetree, bolstering growth in the beauty and personal care market
More ▼
Key statistics
As of last trade IMCD NV (IMCDY:PKL) traded at 75.98, -16.31% below its 52-week high of 90.78, set on Mar 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 76.28 |
---|---|
High | 76.28 |
Low | 75.93 |
Bid | -- |
Offer | -- |
Previous close | 77.27 |
Average volume | 5.69k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 1.30 USD |
---|---|
Annual div yield (ADY) | 1.69% |
Div ex-date | May 01 2023 |
Div pay-date | May 19 2023 |
Data delayed at least 15 minutes, as of Apr 30 2024 20:22 BST.
More ▼